Management of acute bacterial rhinosinusitis

Dennis A Conrad1, Hal B Jenson

  • 1Department of Pediatrics, Division of Infectious Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA. conradd@uthscsa.edu

Insights

Acute bacterial rhinosinusitis in children is diagnosed clinically based on specific symptoms like persistent cough and purulent nasal discharge. High-dose amoxicillin is the recommended initial treatment for this common sinus infection.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Otolaryngology

Background:

  • Acute bacterial rhinosinusitis (ABRS) affects the nasal epithelium and paranasal sinus mucosa in children.
  • Common causative agents include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Purpose of the Study:

  • To outline the clinical diagnosis and management of acute bacterial rhinosinusitis in pediatric patients.
  • To emphasize appropriate initial pharmacotherapy and treatment duration.

Main Methods:

  • Clinical diagnosis based on characteristic symptoms such as prolonged cough and purulent rhinorrhea.
  • Radiographic evaluation is generally not indicated for diagnosis.
  • CT scans are reserved for persistent or complicated cases.

Main Results:

  • Diagnosis relies on symptoms lasting at least 10 days, often with worsening after initial cold symptoms.
  • Facial pain, headache, and fever can also be present.
  • Complications of ABRS in children are infrequent.

Conclusions:

  • High-dose amoxicillin (80-90 mg/kg/day) is the recommended first-line therapy.
  • Treatment duration is typically 10-14 days, continuing for 7 days post-symptom improvement.
  • Prompt and appropriate treatment is crucial for managing pediatric ABRS.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...